Hydroxychloroquine vs Nivolumab

## Hydroxychloroquine vs Nivolumab: Overview

This comparison examines the pharmacological differences between **Hydroxychloroquine** and **Nivolumab**.

## Mechanism of Action

**Hydroxychloroquine**: Accumulates in lysosomes raising pH; inhibits toll-like receptor signaling.

**Nivolumab**: Fully human anti-PD-1 IgG4 monoclonal antibody restoring T-cell anti-tumor activity.

## Pharmacokinetics

**Half-life**: Hydroxychloroquine — 40-50 days; Nivolumab — 27 days.

## Chemical Properties

**Molecular Formula**: Hydroxychloroquine — C18H26ClN3O; Nivolumab — N/A.

**Molecular Weight**: Hydroxychloroquine — 335.8720 g/mol; Nivolumab — N/A.

**Type**: Hydroxychloroquine — Small molecule; Nivolumab — Antibody.